SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-18-028560
Filing Date
2018-04-30
Accepted
2018-04-30 16:20:31
Documents
5
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A a18-3096_3defa14a.htm DEFA14A 32480
2 GRAPHIC g30963bci001.gif GRAPHIC 57498
3 GRAPHIC g30963bci002.gif GRAPHIC 89069
4 GRAPHIC g30963bci003.gif GRAPHIC 30018
5 GRAPHIC g30963bci004.gif GRAPHIC 3992
  Complete submission text file 0001104659-18-028560.txt   282759
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36306 | Film No.: 18790067
SIC: 2834 Pharmaceutical Preparations